Why the study?
Does paroxysmal atrial fibrillation increase the risk of thromboembolic events compared to permanent atrial fibrillation in patients with end-stage renal disease?
Population
219 patients with end-stage renal disease and atrial fibrillation
Comparison
Paroxysmal atrial fibrillation (as an exposure) vs Permanent atrial fibrillation
Design
Cohort
Follow-up
36.9 +/- 21.9 months
Authors
Loading...
May warrant AF-type-specific risk evaluation in ESRD; hypothesis-generating and should not yet change practice.
Does paroxysmal atrial fibrillation increase the risk of thromboembolic events compared to permanent atrial fibrillation in patients with end-stage renal disease?
In patients with end-stage renal disease, paroxysmal atrial fibrillation is associated with a higher risk of thromboembolic events compared to permanent atrial fibrillation, though overall survival is similar.
Chou et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: